Have a feature idea you'd love to see implemented?
Let us know!
FBIO Fortress Biotech Inc
Price (delayed)
$1.61
Market cap
$36.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.23
Enterprise value
$43.89M
Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in
Highlights
Fortress Biotech's EPS has surged by 80% YoY and by 47% QoQ
FBIO's net income has soared by 58% YoY and by 25% QoQ
The gross profit has surged by 69% year-on-year but it has declined by 2.2% since the previous quarter
FBIO's revenue is up by 32% year-on-year but it is down by 2.9% since the previous quarter
The company's equity fell by 22% QoQ and by 3.4% YoY
The debt has increased by 6% YoY
Key stats
What are the main financial stats of FBIO
Market
Valuations
Earnings
Shares outstanding
22.81M
Market cap
$36.73M
Enterprise value
$43.89M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.79
Price to sales (P/S)
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.53
Revenue
$82.62M
EBIT
-$30.85M
EBITDA
-$23.17M
Free cash flow
-$92.97M
Per share
Balance sheet
Liquidity
EPS
-$3.23
Free cash flow per share
-$5.08
Book value per share
$0.9
Revenue per share
$4.51
TBVPS
$6.93
Total assets
$145.69M
Total liabilities
$160.28M
Debt
$85.42M
Equity
$17.88M
Working capital
$27.89M
Debt to equity
4.78
Current ratio
1.37
Quick ratio
1.18
Net debt/EBITDA
-0.31
Margins
Efficiency
Dividend
EBITDA margin
-28%
Gross margin
68.8%
Net margin
-49.2%
Operating margin
-118.3%
Return on assets
-31.5%
Return on equity
-246.7%
Return on invested capital
-59.1%
Return on capital employed
-44%
Return on sales
-37.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
FBIO stock price
How has the Fortress Biotech stock price performed over time
Intraday
2.55%
1 week
11.03%
1 month
-18.27%
1 year
-65.52%
YTD
-46.51%
QTD
11.42%
Financial performance
How have Fortress Biotech's revenue and profit performed over time
Revenue
$82.62M
Gross profit
$56.82M
Operating income
-$97.73M
Net income
-$40.69M
Gross margin
68.8%
Net margin
-49.2%
The gross profit has surged by 69% year-on-year but it has declined by 2.2% since the previous quarter
The net margin has soared by 68% YoY and by 23% QoQ
FBIO's operating margin has surged by 65% year-on-year and by 16% since the previous quarter
FBIO's net income has soared by 58% YoY and by 25% QoQ
Growth
What is Fortress Biotech's growth rate over time
Valuation
What is Fortress Biotech stock price valuation
P/E
N/A
P/B
1.79
P/S
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.53
Fortress Biotech's EPS has surged by 80% YoY and by 47% QoQ
The P/B is 36% less than the 5-year quarterly average of 2.8
The company's equity fell by 22% QoQ and by 3.4% YoY
The P/S is 86% below the 5-year quarterly average of 2.6 and 10% below the last 4 quarters average of 0.4
FBIO's revenue is up by 32% year-on-year but it is down by 2.9% since the previous quarter
Efficiency
How efficient is Fortress Biotech business performance
Fortress Biotech's return on sales has surged by 69% YoY and by 21% QoQ
FBIO's return on invested capital is up by 48% year-on-year and by 37% since the previous quarter
The company's return on equity rose by 21% QoQ and by 5% YoY
The ROA has grown by 19% year-on-year and by 17% since the previous quarter
Dividends
What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for FBIO.
Financial health
How did Fortress Biotech financials performed over time
The total assets is 9% less than the total liabilities
FBIO's quick ratio is up by 42% YoY and by 8% QoQ
Fortress Biotech's current ratio has increased by 38% YoY and by 3% from the previous quarter
The debt to equity is up by 28% since the previous quarter and by 10% year-on-year
The company's equity fell by 22% QoQ and by 3.4% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.